What the law says about pharmacists’ role in the opioid crisis—and how to protect yourself.
Evidence-based framework is an urgent need, study says.
Practical tips to help keep patients safe.
New and old non-opioid pain management solutions.
Patients at-risk for substance abuse more easily identified and managed.
The DEA had access to information about where opioids were being sold, but didn’t act on it. Why?
“Historic investment” distributed to private companies, universities, and researchers.
Controlled substance tramadol among the illegally marketed painkillers.
Approved forms should be considered as options for community distribution.
Fentanyl, oxymorphone, and hydrocodone face greatest cuts.